+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rabeprazole"

Proton Pump Inhibitors Global Market Report 2024 - Product Thumbnail Image

Proton Pump Inhibitors Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Peptic Ulcers - Pipeline Review, H1 2020 - Product Thumbnail Image

Peptic Ulcers - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 65 Pages
  • Global
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Rabeprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Rabeprazole works by blocking the production of acid in the stomach, which helps to reduce symptoms of acid reflux and other gastrointestinal disorders. Rabeprazole is available in both generic and brand-name formulations. It is typically taken once daily, and is available in tablet, capsule, and oral suspension forms. Common side effects of rabeprazole include headache, nausea, diarrhea, and abdominal pain. Rabeprazole is one of the most commonly prescribed PPIs for the treatment of gastrointestinal disorders. It is widely available in pharmacies and is covered by most insurance plans. Some companies that produce rabeprazole include Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Teva Pharmaceuticals. Show Less Read more